Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 4/20 | 0.65 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.65 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.65 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.61 |
| ▸ | BHMT | Q93088 | 2/20 | 0.55 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.55 |
| ▸ | GSR | P00390 | 2/20 | 0.54 |
| ▸ | GRM8 | O00222 | 1/20 | 0.54 |
| ▸ | GRM6 | O15303 | 1/20 | 0.54 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.54 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.54 |
| ▸ | GRM5 | P41594 | 1/20 | 0.54 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.54 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.54 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.54 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.54 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.54 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL255211 | 1.00 | SLC1A3 (0.65) | SLC1A3SLC1A2SLC1A1SLC7A5BHMT | |
| SCHEMBL1531631 | 1.00 | SLC1A3 (0.65) | SLC1A3SLC1A2SLC1A1SLC7A5BHMT | |
| Hydrochloric Acid SCHEMBL20361640 | 0.97 | SLC1A3 (0.63) | SLC1A3SLC1A2SLC1A1SLC7A5BHMT | |
| Hydrochloric Acid SCHEMBL20361639 | 0.97 | SLC1A3 (0.63) | SLC1A3SLC1A2SLC1A1SLC7A5BHMT | |
| SCHEMBL602426 | 0.86 | GSR (0.68) | SLC1A3SLC1A2SLC1A1SLC7A5BHMT | |
| SCHEMBL8068164 | 0.86 | GSR (0.68) | SLC1A3SLC1A2SLC1A1SLC7A5BHMT | |
| SCHEMBL5859579 | 0.85 | GSR (0.64) | SLC1A3SLC1A2SLC1A1SLC7A5GSR | |
| SCHEMBL563055 | 0.85 | GSR (0.58) | SLC1A3SLC1A2SLC1A1SLC7A5GSR | |
| SCHEMBL564047 | 0.85 | GSR (0.58) | SLC1A3SLC1A2SLC1A1SLC7A5GSR | |
| SCHEMBL13343952 | 0.85 | GSR (0.64) | SLC1A3SLC1A2SLC1A1SLC7A5GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023085973-A1 | PHARMACUETICAL COMPOSITIONS FOR TREATING INFLAMMATORY INFECTIOUS DISEASES | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ВАЛЕНТА-ИНТЕЛЛЕКТ" | 2023-05-19 | — | — | WO | claimed |
| CN-113788877-A | Novel insect kinin analogs and application thereof in aphid control | 中国农业大学 | 2021-12-14 | — | — | CN | claimed |
| CN-110799547-A | Compounds for treating, ameliorating or preventing neurological-related disorders and uses thereof | 拜西欧斯（北京）生物技术有限公司 | 2020-02-14 | — | — | CN | claimed |
| WO-2018128826-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2018-07-12 | — | — | WO | claimed |
| WO-2018006063-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2018-01-04 | — | — | WO | claimed |
| CN-104984319-A | TFPI INHIBITORS AND METHODS OF USE | BAXTER INT | 2015-10-21 | — | — | CN | claimed |
| US-8877738-B2 | Antipathogenic peptides | SPIDERBIOTECH S.R.L. (IT) | 2014-11-04 | — | — | US | claimed |
| US-8466108-B2 | TFPI inhibitors and methods of use | BAXTER INTERNATIONAL INC. (US) | 2013-06-18 | — | — | US | claimed |
| EP-2462155-A1 | NOVEL ANTIPATHOGENIC PEPTIDES | Spiderbiotech S.r.l. (IT) | 2012-06-13 | — | — | EP | claimed |
| US-20120121623-A1 | NOVEL ANTIPATHOGENIC PEPTIDES | SPIDERBIOTCH S.r.L. (IT) | 2012-05-17 | — | — | US | claimed |
| CN-102348462-A | Tfpi inhibitors and methods of use | BAXTER INT | 2012-02-08 | — | — | CN | claimed |
| EP-2379096-A2 | TFPI INHIBITORS AND METHODS OF USE | Baxter International Inc. (US) | 2011-10-26 | — | — | EP | claimed |
| WO-2011015628-A1 | NOVEL ANTIPATHOGENIC PEPTIDES | SPIDERBIOTECH S.R.L. (IT) | 2011-02-10 | — | — | WO | claimed |
| WO-2010071894-A2 | TFPI INHIBITORS AND METHODS OF USE | BAXTER INTERNATIONAL INC. (US) | 2010-06-24 | — | — | WO | claimed |
| CN-101400699-A | Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions | BRISTOL MYERS SQUIBB CO (US) | 2009-04-01 | — | — | CN | claimed |
| US-20070238669-A1 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS | BRISTOL-MYERS SQUIBB COMPANY | 2007-10-11 | — | — | US | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| US-4336249-A | MYCOPLANECIN PRODUCT CULTIVATED FORM ACTINOPLANES | SANKYO COMPANY LIMITED (JP) | 1982-06-22 | — | — | US | claimed |
| US-12540141-B2 | Spiropyrrolidine derived antiviral agents | ENANTA PHARMACEUTICALS, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-4012367-A | Anti-ulcer polypeptides containing L-aspartic acid and intermediates thereto | G. D. SEARLE & CO. (US) | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238669-A1 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS | GLP1R, GIPR, IAPP | SLC1A3 2595/4885SLC1A2 3742/4885SLC1A1 3349/4885 |
| US-20120121623-A1 | NOVEL ANTIPATHOGENIC PEPTIDES | MAVS, VIP, ZC3HAV1 | SLC1A3 3406/4885SLC1A2 4492/4885SLC1A1 3574/4885 |
| US-12540141-B2 | Spiropyrrolidine derived antiviral agents | ACE2, NR3C2, ACE | SLC1A3 2891/4885SLC1A2 3977/4885SLC1A1 2641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.